HomeCompareVXTRF vs MRK

VXTRF vs MRK: Dividend Comparison 2026

VXTRF yields 6666666.89% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VXTRF wins by $8.25874132811738e+44M in total portfolio value
10 years
VXTRF
VXTRF
● Live price
6666666.89%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.25874132811738e+44M
Annual income
$825,849,764,240,280,500,000,000,000,000,000,000,000,000,000,000,000.00
Full VXTRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VXTRF vs MRK

📍 VXTRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVXTRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VXTRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VXTRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VXTRF
Annual income on $10K today (after 15% tax)
$566,666,685.56/yr
After 10yr DRIP, annual income (after tax)
$701,972,299,604,238,500,000,000,000,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, VXTRF beats the other by $701,972,299,604,238,500,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VXTRF + MRK for your $10,000?

VXTRF: 50%MRK: 50%
100% MRK50/50100% VXTRF
Portfolio after 10yr
$4.12937066405869e+44M
Annual income
$412,924,882,120,140,300,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VXTRF
No analyst data
Altman Z
-17.5
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VXTRF buys
0
MRK buys
0
No recent congressional trades found for VXTRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVXTRFMRK
Forward yield6666666.89%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$8.25874132811738e+44M$56.8K
Annual income after 10y$825,849,764,240,280,500,000,000,000,000,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$8.258725385650417e+44M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VXTRF vs MRK ($10,000, DRIP)

YearVXTRF PortfolioVXTRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$666,677,389$666,666,688.89$11,206$366.19+$666.67MVXTRF
2$41,538,246,747,390$41,537,533,402,583.80$12,650$502.35+$41538246.73MVXTRF
3$2,418,785,420,797,992,400$2,418,740,974,873,972,700.00$14,407$694.19+$2418785420797.98MVXTRF
4$131,632,552,731,528,880,000,000$131,629,964,631,128,620,000,000.00$16,585$967.82+$131632552731528880.00MVXTRF
5$6,694,930,685,222,868,000,000,000,000$6,694,789,838,391,446,000,000,000,000.00$19,342$1,363.89+$6.694930685222867e+21MVXTRF
6$318,233,377,594,375,670,000,000,000,000,000$318,226,214,018,542,420,000,000,000,000,000.00$22,913$1,947.19+$3.182333775943757e+26MVXTRF
7$14,137,163,415,533,200,000,000,000,000,000,000,000$14,136,822,905,819,175,000,000,000,000,000,000,000.00$27,662$2,823.89+$1.4137163415533202e+31MVXTRF
8$586,942,804,196,016,000,000,000,000,000,000,000,000,000$586,927,677,431,161,500,000,000,000,000,000,000,000,000.00$34,159$4,173.35+$5.86942804196016e+35MVXTRF
9$22,774,365,847,992,805,000,000,000,000,000,000,000,000,000,000$22,773,737,819,192,316,000,000,000,000,000,000,000,000,000,000.00$43,337$6,308.80+$2.2774365847992803e+40MVXTRF
10$825,874,132,811,737,900,000,000,000,000,000,000,000,000,000,000,000$825,849,764,240,280,500,000,000,000,000,000,000,000,000,000,000,000.00$56,776$9,798.13+$8.25874132811738e+44MVXTRF

VXTRF vs MRK: Complete Analysis 2026

VXTRFStock

Voxtur Analytics Corp. operates as a real estate technology company. The company provides automated workflows and targeted data analytics to simplify tax solutions, property valuation, and settlement services for investors, lenders, government agencies, and mortgage servicers. Its solutions include Voxtur Assessment, Voxtur Valuation, Voxtur Settlement Services, and Voxtur Data & Insights. The company offers software that automates and digitizes the appraisal process, including order tracking, job assignment, collaboration, scheduling tools, and mobile apps for appraisers and enterprises; desktop review software for assessors and government agencies that generates customized portals to view multiple elements related to a property, including street level imagery, aerial imagery, building outline sketches, advanced mapping tools, property valuation details, comparable property analysis, and structural characteristics; software that analyzes the accuracy of property assessments to deliver comparable modeling and predictive valuations using proprietary algorithms; and real estate valuation solutions to deliver appraisal and broker price opinion services. It also provides property tax analysis and appeal management platform and sketch software; outsourced property-related services; real estate technology and non-legal default services; and full service title, escrow, and closing services. In addition, the company commercializes client data through the delivery of reports and individual data requests; and customized reports. It serves property lending and property tax sectors in the United States and Canada. The company was formerly known as iLOOKABOUT Corp. and changed its name to Voxtur Analytics Corp. in February 2021. Voxtur Analytics Corp. is headquartered in London, Canada.

Full VXTRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VXTRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VXTRF vs SCHDVXTRF vs JEPIVXTRF vs OVXTRF vs KOVXTRF vs MAINVXTRF vs JNJVXTRF vs ABBVVXTRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.